Thirty-Two Products Developed for Immunophenotyping of Hematologic Malignancies

Thirty-two new clinical flow cytometry reagents have been developed for immunophenotyping of hematologic malignancies.

A provider of reagents for multicolor flow cytometry has expanded its portfolio of antibodies, fluorochromes, and reagents for diagnostics, immunology, oncology, cell biology, and stem cell biology.

eBioscience (San Diego, CA, USA) manufactures the clinical reagents under The Good Manufacturing Practice (GMP) environment. The company assures good signal to noise and more than 90% purity.

The Clinical Flow Cytometry Reagent product line was developed and optimized by eBioscience for the clinical laboratory user. The antibodies are packaged in flexible sizes to help manage precise budgets. All sizes are formulated at 5 µL/test to ensure efficient multicolor immunophenotyping by reducing the ratio of reagent solution to sample volume--critical for conserving precious samples. The wide selection of fluorochrome formats are needed for the variety of cytometers now found in clinical laboratories.

The American Association for Cancer Research (AACR) 102nd Annual Meeting, (April 2–6, 2011) in Orlando (FL, USA) and the XXVI Congress of the International Society for Advancement of Cytometry (CYTO2011), May 2011 in Baltimore, (MD, USA) are showcasing eBioscience's expanding portfolio of clinical reagents.

Related Links:
eBioscience